Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News

November 15, 2011 — The ADVISE clinical trial concluded that a new measure of stenosis severity — instantaneous wave ...

Home November 15, 2011
Home
News

November 15, 2011 — A new clinical trial is testing the efficacy of rotational atherectomy (or rotablation, a process of ...

Home November 15, 2011
Home
News

November 15, 2011 — A clinical trial has shown a drug-eluting stent (DES) with a bioabsorbable polymer has comparable ...

Home November 15, 2011
Home
News

November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary ...

Home November 14, 2011
Home
News

November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...

Home November 14, 2011
Home
News

November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...

Home November 14, 2011
Home
News

November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium ...

Home November 14, 2011
Home
News

November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...

Home November 14, 2011
Home
News

November 14, 2011 — Edwards Lifesciences Corp. announced data were presented on the quality of life impact and cost ...

Home November 14, 2011
Home
News

November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non ...

Home November 11, 2011
Home
News

November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human trial ...

Home November 11, 2011
Home
News

November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...

Home November 11, 2011
Home
News

November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral ...

Home November 10, 2011
Home
News

November 9, 2011 — Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute drug-eluting ...

Home November 09, 2011
Home
Technology

November 9, 2011 — Volcano Corp. announced results from the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluatio ...

Home November 09, 2011
Home
Subscribe Now